Εμφάνιση απλής εγγραφής

dc.creatorMousailidis G., Lachanas V.A., Vasdeki A., Alexopoulos E.I., Kaditis A.G., Petinaki E., Balatsos N., Bizakis J.G., Skoulakis C.E.en
dc.date.accessioned2023-01-31T09:02:04Z
dc.date.available2023-01-31T09:02:04Z
dc.date.issued2018
dc.identifier10.1016/j.ijporl.2018.10.002
dc.identifier.issn01655876
dc.identifier.urihttp://hdl.handle.net/11615/76803
dc.description.abstractObjective: The main objective of the study was to compare preoperative to postoperative levels of urine-Cysteinyl leukotrienes (uCysLT) in children undergoing adenotonsillectomy (AT) for obstructive sleep apnea (OSA) in order to investigate whether exaggerated leukotriene activity is the cause or consequence of OSA. Methods and materials: A prospective study was conducted on non-obese children (4–10 years old) referred for overnight PSG. Children with moderate/severe OSA treated with AT were included. A second PSG study performed 2 months postoperatively to confirm OSA resolution, and those with residual OSA were excluded. Morning urine specimens after both PSG studies were obtained and pre-operative uCysLT levels were compared to postoperative levels. Results: 27 children fulfilled the criteria and underwent a post-operative PSG study with three exclusions for residual OSA (postop-AHI>2), so the study group consisted of 24 children (mean age: 5.7 ± 2.1 years). Mean preoperative and postoperative AHI was 10.96 ± 5.93 and 1.44 ± 0.56 respectively. Mean preop-uCysLT were 21.14 ± 4.65, while after AT they significantly reduced to 12.62 ± 2.67 (P < 0.01). Conclusion: uCysLT levels are significantly reduced after AT in non-obese children with moderate/severe OSA, suggesting that exaggerated leukotriene activity is mainly a consequence of OSA. © 2018 Elsevier B.V.en
dc.language.isoenen
dc.sourceInternational Journal of Pediatric Otorhinolaryngologyen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85054320854&doi=10.1016%2fj.ijporl.2018.10.002&partnerID=40&md5=197331fcc602d3df327d872dad531bd8
dc.subjectbiological markeren
dc.subjectpeptidoleukotrieneen
dc.subjectcysteineen
dc.subjectcysteinyl-leukotrieneen
dc.subjectleukotrieneen
dc.subjectadenotonsillectomyen
dc.subjectapnea hypopnea indexen
dc.subjectArticleen
dc.subjectchilden
dc.subjectclinical articleen
dc.subjectclinical practiceen
dc.subjectconcentration (parameters)en
dc.subjectcontrolled studyen
dc.subjectcorrelational studyen
dc.subjectdisease severityen
dc.subjectfemaleen
dc.subjecthumanen
dc.subjectmaleen
dc.subjectobesityen
dc.subjectpostoperative careen
dc.subjectpreoperative evaluationen
dc.subjectpriority journalen
dc.subjectprospective studyen
dc.subjectrisk assessmenten
dc.subjectrisk reductionen
dc.subjectsleep disordered breathingen
dc.subjectsymptom assessmenten
dc.subjecttreatment durationen
dc.subjecttreatment outcomeen
dc.subjecturinalysisen
dc.subjecturine levelen
dc.subjectadenoidectomyen
dc.subjectchemistryen
dc.subjectpolysomnographyen
dc.subjectpostoperative perioden
dc.subjectpreschool childen
dc.subjectproceduresen
dc.subjectsleep disordered breathingen
dc.subjecttonsillectomyen
dc.subjecturineen
dc.subjectAdenoidectomyen
dc.subjectChilden
dc.subjectChild, Preschoolen
dc.subjectCysteineen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectLeukotrienesen
dc.subjectMaleen
dc.subjectPolysomnographyen
dc.subjectPostoperative Perioden
dc.subjectProspective Studiesen
dc.subjectSleep Apnea, Obstructiveen
dc.subjectTonsillectomyen
dc.subjectUrineen
dc.subjectElsevier Ireland Ltden
dc.titleUrine concentrations changes of cysteinyl leukotrienes in non-obese children with obstructive sleep apnea undergoing adenotonsillectomyen
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής